Current Pathobiology Reports

, Volume 6, Issue 2, pp 117–123 | Cite as

Targeting Pericytes to Improve Wound Healing Outcomes

  • Richard J. Bodnar
  • Latha Satish
Wound Healing and Tissue Repair (CC Yates, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Wound Healing and Tissue Repair


Purpose of Review

Recently, pericytes, a mesenchymal stem-like cell population, has been of great interest due to its plasticity and for its role in different pathologies. This review will focus on the contributions of pericytes specifically to wound healing and the potential to manipulate this specific cell population for better healing outcome.

Recent Findings

Several studies point towards the capability of pericytes to regulate inflammation, angiogenesis and the remodeling phase of healing. Interestingly, findings also show that the source from which pericytes are isolated has differential and varied effects during the process of healing. Pericytes have proven to be beneficial in healing both acute and chronic wounds.


Pericytes have both mesenchymal stem cell-like property and its own signature in regulating signaling cascades and molecules making it a prime candidate for cellular therapy. Several other functions of pericytes are still being explored to further understand its potential for use in therapeutic applications.


Pericytes Fibrosis Wounds Inflammation Myofibroblast 



We thank Mr. Alexander Evdokiou, Shriners Hospitals for Children-Cincinnati, for helpful discussion and comments. We thank Ms. Claudia Roth, Shriners Hospitals for Children-Cincinnati, for her assistance in preparing Fig. 1.

Compliance with Ethical Standards

Conflict of Interest

The authors have no conflict of interest to declare.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult mesenchymal stem cells. Science. 1999;284:143–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Corselli M, Chen CW, Crisan M, Lazzari L, Péault B. Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol. 2010;30:1104–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circul Res. 2005;97:512–23.CrossRefGoogle Scholar
  4. 4.
    Paquet-Fifield S, Schluter H, Li A, Aitken T, Gangatirkar P, Blashki D, et al. A role of pericytes as microenvironmental regulators of human skin tissue regeneration. J Clin Invest. 2009;119:2795–806.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003;314:15–23.CrossRefPubMedGoogle Scholar
  6. 6.
    Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301–13.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dar A, Domev H, Ben-Yosef O, Tzukerman M, Zeevi-Levin N, Novak A, et al. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation. 2012;125:87–99.CrossRefPubMedGoogle Scholar
  8. 8.
    •• Guimarães-Camboa N, Cattaneo P, Sun Y, Moore-Morris T, Gu Y, Dalton ND, et al. Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo. Cell Stem Cell. 2017;20:345–59. This study provides experimental results suggesting that pericytes may not behave as mesenchymal cells in vivo. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Yamanishi E, Takahashi M, Saga Y, Osumi N. Penetration and differentiation of cephalic neural crest-derived cells in the developing mouse telencephalon. Develop Growth Differ. 2012;54:785–800.CrossRefGoogle Scholar
  10. 10.
    Asahina K, Zhou B, Pu WT, Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology. 2011;53:983–95.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J, et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature. 2008;454:109–13.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen Q, Zhang H, Liu Y, Adams S, Eilken H, Stehling M, et al. Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells. Nat Commun. 2016;7:12422.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    • Yamazaki T, Nalbandian A, Uchida Y, Li W, Arnold TD, Kubota Y, et al. Tissue myeloid progenitors differentiate into pericytes through TGF-β signaling in developing skin vasculature. Cell Rep. 2017;18:2991–3004. This study provided data that suggests that pericytes differentiate from tissue myeloid progenitors in the skin vasculature through TGF-β signaling. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Laaff H, Vandscheidt W, Weiss JM, Schaefer HE, Schoepf E. Immunohistochemical investigation of pericytes in chronic venous insufficiency. Vasa. 1991;20:323–8.PubMedGoogle Scholar
  15. 15.
    Pietras K, Östman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316(8):1324–31.CrossRefPubMedGoogle Scholar
  16. 16.
    Wang S, Cao C, Chen Z, Bankaitis V, Tzima E, Sheibani N, et al. Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS One. 2012;7:e45499.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hung CF, Mittelsteadt KL, Brauer R, McKinney BL, Hallstrand TS, Parks WC, et al. Lung pericyte-like cells are functional interstitial immune sentinel cells. Am J Physiol Lung Cell Mol Physiol. 2017;312:L556–67.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    • Leaf IA, Nakagawa S, Johnson BG, Cha JJ, Mittelsteadt K, Guckian KM, et al. Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury. J Clin Invest. 2017;127:321–34. In this study, authors report a new therapeutic approach to target pericytes by disrupting the MyD88-dependent pathway to inhibit fibrogenesis and promote regeneration. CrossRefPubMedGoogle Scholar
  19. 19.
    Uchiyama A, Yamada K, Ogino S, Yokoyama Y, Takeuchi Y, Udey MC, et al. MFG-E8 regulates angiogenesis in cutaneous wound healing. Am J Pathol. 2014;184:1981–90.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Das A, Ghatak S, Sinha M, Chaffee S, Ahmed NS, Parinandi NL, et al. Correction of MFG-E8 resolves inflammation and promotes cutaneous wound healing in diabetes. J Immunol. 2016;196:5089–100.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    • Yamamoto S, Niida S, Azuma E, Yanagibashi T, Muramatsu M, Huang TT, et al. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci Rep. 2015;5:8505. This study provides evidence to target endothelial cell-derived extracellular vesicles for the treatment of inflammatory diseases. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Morikawa S, Ezaki T. Phenotypic changes and possible angiogenic roles of pericytes during wound healing in the mouse skin. Histol Histopathol. 2011;26:979–95.PubMedGoogle Scholar
  23. 23.
    Bodnar RJ, Rodgers ME, Chen WC, Wells A. Pericyte regulation of vascular remodeling through the CXC receptor 3. Arterioscler Thromb Vasc Biol. 2013;33:2818–29.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170:1807–16.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Greenhalgh SN, Conroy KP, Henderson NC. Healing scars: targeting pericytes to treat fibrosis. Q J Med. 2015;108:3–7.CrossRefGoogle Scholar
  26. 26.
    Greenhalgh SN, Iredale JP, Henderson NC. Origins of fibrosis: pericytes take centre stage. F1000prime Rep. 2013;5:37.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    •• Mills SJ, Zhuang L, Arandjelovic P, Cowin AJ, Kaur P. Effects of human pericytes in a murine excision model of wound healing. Exp Dermatol. 2015;24:881–2. This study provides data suggesting that pericytes implantation on to the excisional wounds delayed dermal resolution but re-epithelialization and wound closure remain unaffected. CrossRefPubMedGoogle Scholar
  28. 28.
    Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007;25:19–25.CrossRefPubMedGoogle Scholar
  29. 29.
    Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. J Plast Reconstr Surg. 2006;117:35–41.CrossRefGoogle Scholar
  30. 30.
    Dulmovits BM, Herman IM. Microvascular remodeling and wound healing: a role for pericytes. Int J Biochem Cell Biol. 2012;4:1800–12.CrossRefGoogle Scholar
  31. 31.
    Braverman IM, Sibley J, Keh A. Ultrastructural analysis of the endothelial-pericyte relationship in diabetic cutaneous vessels. J Invest Dermatol. 1990;95:147–53.CrossRefPubMedGoogle Scholar
  32. 32.
    Hohman TC, Nishimura C, Robison WG. Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp Eye Res. 1989;48:55–60.CrossRefPubMedGoogle Scholar
  33. 33.
    Shakya S, Wang Y, Mack JA, Maytin EV. Hyperglycemia-induced changes in hyaluronan contribute to impaired skin wound healing in diabetes: review and perspective. Int J Cell Biol. 2015;2015:701738.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Feng J, Mineda K, Wu SH, Mashiko T, Doi K, Kuno S, et al. An injectable non-cross-linked hyaluronic-acid gel containing therapeutic spheroids of human adipose-derived stem cells. Sci Rep. 2017;7:1548.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Motegi S, Leitner WW, Lu M, Tada Y, Sárdy M, Wu C, et al. Pericyte-derived MFG-E8 regulates pathologic angiogenesis. Arterioscler Thromb Vasc Biol. 2011;31:2024–34.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Chen CW, Okada M, Proto JD, Gao X, Sekiya N, Beckman SA, et al. Human pericytes for ischemic heart repair. Stem Cells. 2013;31:305–16.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Park TS, Gavina M, Chen CW, Sun B, Teng PN, Huard J, et al. Placental perivascular cells for human muscle regeneration. Stem Cells Dev. 2011;20:451–63.CrossRefPubMedGoogle Scholar
  38. 38.
    •• König MA, Canepa DD, Cadosch D, Casanova E, Heinzelmann M, Rittirsch D, et al. Direct transplantation of native pericytes from adipose tissue: a new perspective to stimulate healing in critical size bone defects. Cytotherapy. 2016;18:41–52. This study provides evidence showing that direct use of pericyte population contribute to the regeneration in a mouse model for critical size bone injury. CrossRefPubMedGoogle Scholar
  39. 39.
    •• Eliasberg CD, Dar A, Jensen AR, Murray IR, Hardy WR, Kowalski TJ, et al. Perivascular stem cells diminish muscle atrophy following massive rotator cuff tears in a small animal model. J Bone Joint Surg Am. 2017;99:331–41. This study provides experimental findings demonstrating that significantly less muscle atrophy was noted in animals that received injections of perivascular stem cells, pericytes after supraspinatus, and infraspinatus tendon transection CrossRefPubMedGoogle Scholar
  40. 40.
    • Wu CC, Liu FL, Sytwu HK, Tsai CY, Chang DM. CD146+ mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther. 2016;7:23. This study suggests the therapeutic efficiency of CD146+ cells as it has potency for cartilage protection by suppressing Th17 cell activation. CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Esteves CL, Donadeu FX. Pericytes and their potential in regenerative medicine across species. Cytometry A 2017.Google Scholar
  42. 42.
    Kramann R, Fleig SV, Schneider RK, Fabian SL, DiRocco DP, Maarouf O, et al. Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest. 2015a;125:2935–51.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015b;16:51–66.CrossRefPubMedGoogle Scholar
  44. 44.
    • Wang N, Deng Y, Liu A, Shen N, Wang W, Du X, et al. Novel mechanism of the pericyte-myofibroblast transition in renal interstitial fibrosis: core fucosylation regulation. Sci Rep. 2017;7:16914. This study provides data showing that fucosylation may regulate the pericyte transition to myofibroblast in RIF. CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Sun W, Tang H, Gao L, Sun X, Liu J, Wang W, et al. Mechanisms of pulmonary fibrosis induced by core fucosylation in pericytes. Int J Biochem Cell Biol. 2017;88:44–54.CrossRefPubMedGoogle Scholar
  46. 46.
    Smith SW, Eardley KS, Croft AP, Nwosu J, Howie AJ, Cockwell P, et al. CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int. 2011;80:199–207.CrossRefPubMedGoogle Scholar
  47. 47.
    Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, et al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol. 2009;34:619–27.CrossRefPubMedGoogle Scholar
  48. 48.
    • Smith SW, Croft AP, Morris HL, Naylor AJ, Huso DL, Isacke CM, et al. Genetic deletion of the stromal cell marker CD248 (endosialin) protects against the development of renal fibrosis. Nephron. 2015;131:265–77. This study provides evidence for targeting a transmembrane glycoprotein, namely, CD248, to inhibit renal fibrosis through modulation of pericyte and stromal cell functions CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A. 1985;82:8681–5.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A. 2012;109:9448–53.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    • Zhang F, Hao M, Jin H, Yao Z, Lian N, Wu L, et al. Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis. Br J Pharmacol. 2017;174:409–23. This study provides findings to inhibit hepatic fibrosis by selective inhibition of hepatic stellate cells hedgehog signaling CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM, Abraham DJ. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther. 2005;7(5):R1113–23.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Liu S, Taghavi R, Leask A. Connective tissue growth factor is induced in bleomycin-induced skin scleroderma. J Cell Commun Signal. 2010;4:25–30.CrossRefPubMedGoogle Scholar
  54. 54.
    Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med. 2012;18(8):1262–70.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Veterans Affairs Medical CenterPittsburghUSA
  2. 2.Research DepartmentShriners Hospitals for Children-CincinnatiCincinnatiUSA
  3. 3.Department of Pathology and Laboratory MedicineUniversity of CincinnatiCincinnatiUSA

Personalised recommendations